The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Fann, J. R.
* Articles by Katon, W. J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Fann, J. R.
* Articles by Katon, W. J.
Related Collections
* Depression
J Neuropsychiatry Clin Neurosci 12:226-232, May 2000
© 2000 American Psychiatric Press, Inc.

Sertraline in the Treatment of Major Depression Following Mild Traumatic Brain Injury

Jesse R. Fann, M.D., M.P.H., Jay M. Uomoto, Ph.D. and Wayne J. Katon, M.D.

Received June 22, 1999; revised July 30, 1999; accepted September 1, 1999. From the Department of Psychiatry and Behavioral Sciences, University of Washington, and the Department of Graduate Psychology, Seattle Pacific University, Seattle, Washington. Address correspondence to Dr. Fann, Department of Psychiatry and Behavioral Sciences, Box 356560, University of Washington, Seattle, WA 98195.

An 8-week, nonrandomized, single-blind, placebo run-in trial of sertraline was conducted on 15 patients diagnosed with major depression between 3 and 24 months after a mild traumatic brain injury. On the Hamilton Rating Scale for Depression, 13 (87%) had a decrease in score of >=50% ("response"), and 10 (67%) achieved a score of <=7 ("remission") by week 8 of sertraline. There was statistically significant improvement in psychological distress, anger and aggression, functioning, and postconcussive symptoms with treatment.

Key Words: Depression • Traumatic Brain Injury • Sertraline




This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
J. M. Silver, T. W. McAllister, and D. B. Arciniegas
Depression and Cognitive Complaints Following Mild Traumatic Brain Injury
Am J Psychiatry, June 1, 2009; 166(6): 653 - 661.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
S. Vaishnavi, V. Rao, and J. R. Fann
Neuropsychiatric Problems After Traumatic Brain Injury: Unraveling the Silent Epidemic
Psychosomatics, May 1, 2009; 50(3): 198 - 205.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
N. Herrmann, M. J. Rapoport, R. D. Rajaram, F. Chan, A. Kiss, A. K. Ma, A. Feinstein, S. MCCullagh, and K. L. Lanctot
Factor Analysis of the Rivermead Post-Concussion Symptoms Questionnaire in Mild-to-Moderate Traumatic Brain Injury Patients
J Neuropsychiatry Clin Neurosci, May 1, 2009; 21(2): 181 - 188.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
M. Rapoport, F. Chan, K. Lanctot, N. Herrmann, S. McCullagh, and A. Feinstein
An open-label study of citalopram for major depression following traumatic brain injury
J Psychopharmacol, November 1, 2008; 22(8): 860 - 864.
[Abstract] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
A. Tateno, R. E. Jorge, and R. G. Robinson
Clinical Correlates of Aggressive Behavior After Traumatic Brain Injury
J Neuropsychiatry Clin Neurosci, May 1, 2003; 15(2): 155 - 160.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
M. J. Rapoport, S. McCullagh, D. Streiner, and A. Feinstein
The Clinical Significance of Major Depression Following Mild Traumatic Brain Injury
Psychosomatics, February 1, 2003; 44(1): 31 - 37.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
J. R. Fann, J. M. Uomoto, and W. J. Katon
Cognitive Improvement With Treatment of Depression Following Mild Traumatic Brain Injury
Psychosomatics, February 1, 2001; 42(1): 48 - 54.
[Abstract] [Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 2000 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org